Cytokeratin 7 antibody (N-Term)
-
- Target See all Cytokeratin 7 (KRT7) Antibodies
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
-
Binding Specificity
- AA 22-38, N-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Monoclonal
-
Conjugate
- This Cytokeratin 7 antibody is un-conjugated
-
Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purpose
- Anti-Cytokeratin 7
- Specificity
- Cytokeratin 7
- Immunogen
- Peptide derived from N-terminal sequence of human cytokeratin 7. Antibody recognizes the epitope between Ala22 - Ser38.
- Clone
- R17-S
- Isotype
- IgG
- Top Product
- Discover our top product KRT7 Primary Antibody
-
-
- Application Notes
- 1:100 - 200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C
- Storage Comment
- +2 °C to +8 °C
-
- Target
- Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
- Alternative Name
- Cytokeratin 7 (KRT7 Products)
- Background
- Low molecular weight cytokeratin. Its expression is restricted to the epithelia and theirs neoplasms. Overexpression of CK7 had been detected in the majority of epithelial carcinomas. It is successfully used in detection of renal cell carcinomas, ovarian metastatic carcinomas and in discriminating the primary pulmonary adenocarcinoma from metastatic adenocarcinoma.
- UniProt
- P08729
-